GLS and breast cancer: In another article published recently, expression of FDX1, DLD, DLAT, LIAS, LIPT1, GLS MTF1, and PDHA1 was downregulated, while CDKN2A expression level was elevated in BC [19]; poor survival was associated with high levels of CDKN2A and PDHA1 and low levels of MTF1, DLD, LIPT1, and FDX1.